NASDAQ
Health Sciences Acquisitions Corporation 2 (HSAQ) has a price/sales ratio of 15262.14x as of Friday, May 22, 2026. This represents a 67.14% decrease compared to its 12-month average of 46445.04x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.